Jinyu Bio-technology Co., Ltd. (SHA:600201)

Market Cap	7.91B
Revenue (ttm)	1.26B
Net Income (ttm)	79.88M
Shares Out	1.12B
EPS (ttm)	0.07
PE Ratio	97.41
Forward PE	38.36
Dividend	0.03 (0.41%)
Ex-Dividend Date	Jul 15, 2024

Volume	12,521,800
Average Volume	17,804,342
Open	7.08
Previous Close	7.08
Day's Range	7.04 - 7.15
52-Week Range	5.62 - 10.95
Beta	0.71
RSI	50.85
Earnings Date	Apr 25, 2025

About Jinyu Bio-technology

Jinyu Bio-technology Co., Ltd. engages in the research and development, production, and sale of veterinary products in China. Its product portfolio includes Jinyu Baoling, Yangzhou Youbang, and Liaoning Yikang animal vaccines for the prevention of foot, porcine, mycoplasma pneumoniae, porcine reproductive and respiratory syndrome, porcine pseudorabies, pathogenic avian influenza, brucellosis bacterial disease, bovine viral diarrhea and mucosal, infectious rhinotracheitis, and other domestic animal diseases. The company was founded in 1992 and i...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1992
• Employees: 1,654
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600201

Financial Performance

In 2024, Jinyu Bio-technology's revenue was 1.26 billion, a decrease of -21.45% compared to the previous year's 1.60 billion. Earnings were 108.99 million, a decrease of -61.57%.